Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 7:8:548335.
doi: 10.3389/fcell.2020.548335. eCollection 2020.

Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins

Juan Li  1 , Ying Zhu  2   3
Affiliations
Review

Recent Advances in Liver Cancer Stem Cells: Non-coding RNAs, Oncogenes and Oncoproteins

Juan Li et al. Front Cell Dev Biol. .

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide, with high morbidity, relapse, metastasis and mortality rates. Although liver surgical resection, transplantation, chemotherapy, radiotherapy and some molecular targeted therapeutics may prolong the survival of HCC patients to a certain degree, the curative effect is still poor, primarily because of tumor recurrence and the drug resistance of HCC cells. Liver cancer stem cells (LCSCs), also known as liver tumor-initiating cells, represent one small subset of cancer cells that are responsible for disease recurrence, drug resistance and death. Therefore, understanding the regulatory mechanism of LCSCs in HCC is of vital importance. Thus, new studies that present gene regulation strategies to control LCSC differentiation and replication are under development. In this review, we provide an update on the latest advances in experimental studies on non-coding RNAs (ncRNAs), oncogenes and oncoproteins. All the articles addressed the crosstalk between different ncRNAs, oncogenes and oncoproteins, as well as their upstream and downstream products targeting LCSCs. In this review, we summarize three pathways, the Wnt/β-catenin signaling pathway, phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway, and interleukin 6/Janus kinase 2/signal transducer and activator of transcription 3 (IL6/JAK2/STAT3) signaling pathway, and their targeting gene, c-Myc. Furthermore, we conclude that octamer 4 (OCT4) and Nanog are two important functional genes that play a pivotal role in LCSC regulation and HCC prognosis.

Keywords: hepatocellular carcinoma; liver cancer stem cells; non-coding RNAs; oncogenes; oncoproteins.

PubMed Disclaimer

References

    1. Aceto N., Sausgruber N., Brinkhaus H., Gaidatzis D., Martiny-Baron G., Mazzarol G., et al. (2012). Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nat. Med. 18 529–537. 10.1038/nm.2645 - DOI - PubMed
    1. Alberti L., Losi L., Leyvraz S., Benhattar J. (2015). Different effects of BORIS/CTCFL on stemness gene expression, sphere formation and cell survival in epithelial cancer stem cells. PLoS One 10:e0132977. 10.1371/journal.pone.0132977 - DOI - PMC - PubMed
    1. Alberti L., Renaud S., Losi L., Leyvraz S., Benhattar J. (2014). High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells. PLoS One 9:e109921. 10.1371/journal.pone.0109921 - DOI - PMC - PubMed
    1. Aledo J. C., Gomez-Fabre P. M., Olalla L., Marquez J. (2000). Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm. Genome 11 1107–1110. 10.1007/s003350010190 - DOI - PubMed
    1. Androutsellis-Theotokis A., Leker R. R., Soldner F., Hoeppner D. J., Ravin R., Poser S. W., et al. (2006). Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442 823–826. 10.1038/nature04940 - DOI - PubMed